Background/Aims: Metastasis is the primary cause of colorectal cancer (CRC)-related death. However, the molecular mechanisms underlying metastasis in CRC remain unclear. Methods: We evaluated mRNA and protein expression levels by quantitative real-time reverse transcription PCR, western blotting, immunofluorescence, tissue microarrays, and immunohistochemistry assays. We also assessed the migration and invasion abilities of CRC cells in vitro by wound healing assays, invasion and migration assays, western blot analysis, and immunofluorescence. Tumor metastasis was evaluated in nude mice in vivo. Results: A positive correlation was observed between the expression patterns of Forkhead box k1 (FOXK1) and Snail in CRC. Luciferase reporter and chromatin immunoprecipitation assays demonstrated that Snail directly bound to and activated the human FOXK1 gene promoter. Moreover, the Snail-FOXK1 axis promote epithelial mesenchymal transition (EMT)-mediated CRC cell invasion and metastasis. FOXK1 and Snail expression levels were correlated with tumor progression and served as significant predictors of overall survival in patients with CRC. Furthermore, overexpression of FOXK1 induced the EMT by upregulating the expression of cysteine-rich angiogenic inducer 61 (Cyr61). Luciferase assays showed that Cyr61 was a direct transcriptional target of FOXK1. Down regulation of Cyr61 decreased FOXK1-enhanced "CRC cell" migration, invasion, and metastasis. Additionally, FOXK1 expression was positively correlated with Cyr61 expression and was associated with poor prognosis. Conclusions: The Snail/FOXK1/Cyr61 signaling axis regulates the EMT and metastasis of CRC.
Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
Xiaoting
Introduction
The epithelial-mesenchymal transition (EMT) is a well-recognized process by which cells in a differentiated epithelial state convert into a dedifferentiated mesenchymal state, and plays an essential role in the regulation of embryogenesis, organ fibrosis, wound healing, and cancer metastasis [1] [2] [3] . Crucial events of the EMT include decreased expression of the cell-cell adhesion molecule E-cadherin, increased expression of mesenchymal proteins such as vimentin and N-cadherin, and deregulation of the canonical Wnt/β-catenin signaling pathway [4] [5] . It has been shown that colorectal cancer (CRC) cells that undergo the EMT acquire invasive and migratory properties [5] [6] . A number of transcription factors such as Twist [6] , Snail [7] , Slug, [8] and zinc finger E-box-binding homeobox 1 (ZEB1)/2 [9] are major inducers of the EMT and directly or indirectly repress E-cadherin in CRC cells [10] . Thus, CRC patients may benefit from targeted therapies that inhibit the EMT.
Forkhead box k1 (FOXK1), a transcription factor that belongs to the forkhead family, consists of the winged-helix DNA-binding domain and N-terminal and C-terminal transcriptional domains [11] . FOXK1 has been shown to induce the EMT [12, 13] and promote CRC cell invasion in vitro [14] . In addition, we recently found that FOXK1 promotes tumor metastasis through induction of the EMT, thereby maintaining the invasive potential of gastric cancer cells [13, 15] . Snail is a zinc-finger transcription factor that triggers the EMT by directly repressing E-cadherin expression [7] . Snail overexpression in different epithelial cells leads to conversion from a well-differentiated phenotype to a mesenchymal/ fibroblastic phenotype at the same time that E-cadherin expression is repressed, resulting in the acquisition of invasive and migratory properties [16] [17] . Snail binds to the E-box nucleotide sequence CANNTG in the promoter regions of target genes [18] . However, the effects of FOXK1 and Snail on the EMT process in CRC have not been investigated.
Cysteine-rich angiogenic inducer 61 (Cyr61) is a member of the Cyr61/CTGF/Nov (CCN) protein family, which consists of Cyr61 (CCN1), connective tissue growth factor (CTGF/CCN2), and nephroblastoma-overexpressed gene (Nov/CCN3) [19] [20] [21] . Cyr61 is up regulated in many cancers, such as breast [19] , esophagus [22] , and colorectal cancers [23] . Several studies have reported that Cyr61 promotes the EMT and tumor metastasis [24, 25] .
In this study, we demonstrated that FOXK1, a direct transcriptional target of Snail, promoted CRC invasion and metastasis by up regulating Cyr61expression. In addition, the Snail/FOXK1/Cyr61 signaling axis was associated with CRC metastasis and indicative of poor prognosis.
Materials and Methods
Chemicals, reagents, and cell lines Mouse E-cadherin (H-108), rabbit anti-FOXK1 (H-140), anti-Cyr61(H-78), mouse anti-glyceraldehydes 3-phosphate dehydrogenase (GAPDH), E-cadherin (H-108), and horseradish peroxidase conjugated secondary antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit antivalentine (Ag0489), matrix metalloproteinase-2 (MMP-2) (Ag0549), and MMP-9 (Ag0552) were acquired from Proteintech (Wuhan, China). Snail (O95863) was obtained from Abcam (Cambridge, UK). We used two colon carcinoma cell lines: LoVo and SW480, which were purchased from American Type Culture Collection (Rockville, MD, USA) and cultured in RPMI-1640 medium as previously described [12] .
Plasmid construction and small interfering RNA transfection FOXK1 plasmid was described as in our previous publication [12] . pENTER-Snail and empty vector (pENTER) plasmids encoding a FLAG tag were purchased from Vigene Biosciences (Rockville, MD, USA). Viable clones were pooled, screened for FOXK1 or Snail expression, and maintained in medium containing 600µg/mL Geneticin Selective Antibiotic (G418;Calbiochem, Darmstadt, Germany) for additional studies. For RNA interference studies, CRC cells were transfected with predesigned small interfering RNAs (siRNAs) at final concentrations of 25 nM, as previously described [12, 18] . The siRNA sequences were as follows: FOXK1 sense strand: 586-CCAUCAAGAUCCAGUUCAC (dTdT)-605 and Cyr61 sense strand: 876-GCAUCCUAUACAACCCTTTAC-897; scrambled (src) siRNA 5′-UUCUCCGAACGUGUCACGU-3′, which did not target any gene, was used as the negative control. The siRNA transfections were performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. At 48 h post transfection, cells were lysed and western blot analyses were performed. Cells seeded in tissue culture plates were grown to 30-50% confluence and transfected using Lipofectamine 2000 or LipofectamineRNAiMAX according to the manufacturer's instructions. The effect of gene knockdown was evaluated by western blotting 36h post transfection.
Construction of tissue microarrays and immunohistochemistry
CRC samples and the corresponding adjacent colorectal tissues were used to construct a tissue microarray (TMA; Shanghai Biochip Co., Ltd., Shanghai, China). The tissue microarray was stained for FOXK1, Cyr61, and Snail expression. The TMA was scored independently by two pathologists for both staining intensity and extent of protein expression across the section. Immunohistochemical staining was performed using the Dako Envision Plus System (Dako, Carpinteria, CA, USA) according to the manufacturer's instructions. Analysis was performed by two independent observers who were blinded to the clinical outcome. Staining intensity was scored as 0, negative staining; 1, weak staining; 2, moderate staining; and 3, intense staining. Cells with negative or weak staining were defined as low expressers, and cells with moderate or intense staining were defined as high expressers, as previously described [12, 15] . This study was approved by the institutional human ethics committee of the relevant institutions.
RNA extraction and quantitative real-time reverse transcription polymerase chain reaction
Total RNA extraction and reverse transcription were performed as previously described [18] . Quantitative real-time reverse transcription PCR (qRT-PCR) was performed using the Applied Biosystems Sequence Detection System 7900 (ABI Prism 7900HT; Applied Biosystems Inc., Foster City, CA, USA) with a 10 mL mixture comprising the Power SYBR GREEN PCR Master Mix (Applied Biosystems), 500 nmol of each primer, and 300 ng complementary DNA template. The reactions were performed with an initial denaturation step of 95°C for 5 min, followed by 60 cycles of 20 s at 94°C, 20 s at 55°C, and 40 s at 72°C. A final extension at 72°C for 5 min was included before a temperature increase from 72°C to 95°C at 0.1°C/s with continuous fluorescent acquisition. Each complementary DNA sample was run in duplicate for each real-time PCR assay, and average relative fold change in mRNA levels was determined using the 2-ΔΔCt method, with GAPDH used as the internal control.
Preparation of cell lysates and immunoblotting
Culture medium was removed and the cells were washed with cold phosphate-buffered saline (PBS) and lysed in precooled mammalian cell lysis buffer (40 mM HEPES [pH 7.4], 1% Triton X-100, 100mM NaCl, 1mM ethylenediaminetetraacetic acid (EDTA), 25 mM β -glycerol phosphate, 1mM sodium orthovanadate, 10μg/ mL leupeptin, and 10 μg/mL aprotinin). The sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) samples were prepared by directly adding 5× sodium dodecyl sulfate (SDS) sample buffer to the lysates, followed by vortexing and denaturing at 100°C for 5 min. Proteins were resolved on 12% SDS-PAGE gels and electro transferred onto immobilon polyvinylidene fluoride membranes (Millipore, Stafford, VA, USA).The membranes were incubated with primary antibodies overnight at 4°C, followed by incubation with secondary antibodies for 2 h at room temperature. The protein bands were detected using the Western Lightning ECL Detection Kit (Beyotime, Beijing, China).
Invasion and cell migration assays
Invasion and cell migration assays were performed as previously described [26] . Briefly, cells were plated in 6 well plates; once they were 100% confluent, they were wounded with a pipette tip at time 0. Media were changed to remove the cell debris and the cells were cultured in the presence of 10µg/mL mitomycin C to inhibit cell proliferation. Photographs were taken after 60 h. Cells were plated in serumfree medium on transwell inserts (Corning, NY, USA) coated with 25μg Matrigel (BD Biosciences, San Jose, CA, USA) for the invasion assays. After incubation for 48 h at 37°C/5% CO2, the inserts were fixed in 3.7% paraformaldehyde/PBS and stained with 2% crystal violet. The number of invading/migrating cells was counted in five representative fields (200×) per insert.
Cellular Physiology and Biochemistry

Promoter reporter and dual luciferase assays First, 482 base pairs (bp) (FOXK1p1), 597bp (FOXK1p2), and 31bp (Cyr61p) fragments of the FOXK1 and Cyr61 promoter upstream of the transcription start site were cloned into the pGL3 basic vector. For the luciferase assay, cells were transiently transfected with the various pLuc constructs using Lipofectamine 2000. The firefly and Renilla luciferase activities were measured using the Dual-Luciferase reporter system (Promega, Madison, WI, USA) with a luminometer (TD-20/20; EG&G Berthold, Australia). The firefly luciferase enzyme activity was normalized to the renilla luciferase enzyme activity. The transcriptional activity at the promoter was presented as the fold induction of relative luciferase units (RLUs) compared with the basic pGL3 vector control. The RLU was the value of the firefly luciferase unit divided by the value of the Renilla luciferase unit. All treatments were performed in triplicate for each experiment. Site-directed mutagenesis of potential Snail or Cyr61 binding sites was conducted in the FOXK1p1, FOXK1p2, and Cyr61 plasmids using the Clon Express II One Step Cloning Kit (Vazyme, Nanjing, China). All mutations were verified by sequencing.
Chromatin immunoprecipitation assay
Cells that were transfected with the appropriate plasmids were cross-linked in 1% formaldehyde at 37°C for 10 min. After washing with PBS, cells were resuspended in 300mL lysis buffer (50 mM Tris [pH 8.1], 10 mM EDTA, 1%SDS, and 1 mM phenylmethylsulfonyl fluoride). DNA was sheared to small fragments by sonication. Supernatants were precleared using herring sperm DNA/Protein G-Sepharose slurry (SigmaAldrich, St. Louis, MO, USA). Recovered supernatants were incubated with specific antibodies or an isotype control immunoglobulin G for 2 h in the presence of herring sperm DNA and protein G-Sepharose beads. Immunoprecipitated DNA was retrieved from the beads with 1% SDS and a 1. 1M NaHCO3 solution at 65°C for 6 h. Then the DNA was purified using a PCR Purification Kit (Qiagen, Valencia, CA, USA).
Immunofluorescence
For staining of F-actin, cells were washed with PBS and fixed in methanol/acetone (1:1) for 5 min on ice, followed by incubation with rhodamine-conjugated phallotoxin (5 U/mL, Molecular Probes, Eugene, OR, USA) in PBS at a 1:40 dilution for 1h. Coverslips were washed, stained with DAPI, and mounted on slides. Nuclei were stained with 1 μg/mL Hoechst 33258, and cells were visualized by fluorescence microscopy.
Construction of lentivirus and stable cell lines
Lentiviral vectors encoding short hairpin RNAs (shRNAs) were generated using PLKO.1-TRC (Addgene, Cambridge, MA, USA) and designated as LV-shFOXK1, LV-shCyr61, and LV-shcontrol (non-target shRNA control). The vector "pLKO.1-puro Non-Target shRNA Control Plasmid DNA" (SHC016;Sigma) contained an shRNA insert that did not target any known genes from any species. The shRNA sequences were: shFOXK1, 5'-CCAUCAAGAUCCAGUUCAC-3; and shCyr61, 5'-GCATCCTATACAACCCTTTAC-3. Lentiviral vectors encoding human FOXK1 and Snail genes were constructed in FUW-teto (Addgene) and designated as LV-FOXK1 and LVSnail, respectively. An empty vector, designated LV-control, was used as the negative control. Concentrated lentivirus was transfected into CRC cells at a multiplicity of infection ranging from 30 to 50 in the presence of polybrene (6 μg/mL).After 72 h, CRC cells were selected for 2 weeks using 2.5 μg/mL puromycin (OriGene Technologies Inc., Rockville, MD, USA). Selected pools of knockdown and over expressing cells were used for subsequent experiments.
In vivo metastatic model and bioluminescent imaging BALB/C nude mice (4-6 weeks old) were housed under standard conditions and cared for according to the institutional guidelines for animal care. All animal experiments were approved by the Committee on the Use of Live Animals in Teaching and Research, Southern Medical University (Guangdong, China). The 4-6-week-old BALB/C-nu/nu nude mice were obtained from the Laboratory Animal Unit, Southern Medical University. To evaluate the metastatic potential of CRC cells in vivo,SW480/pEGFP-N1, SW480/ pEGFP-FOXK1, SW480/pEGFP-src shRNA, and SW480/pEGFP-FOXK1 shRNA-transfected cells (density of 5×106 cells/plate)were inoculated into the dorsal subcostal incision to expose the spleen (n= 3 for each group). A 50 μL volume of tumor cell suspension was slowly injected into the spleen using a 25-gauge needle. After 42 days, the mice were sacrificed, and individual organs were removed and assessed using the In-Vivo Imaging System (Kodak, Rochester, NY, USA). The metastatic tissues were analyzed by hematoxylin and eosin staining, immunohistochemistry (IHC), and qRT-PCR.
Statistical analysis
Quantitative data obtained from experiments with biological replicates are shown as the mean ± standard deviation. Comparisons between groups were conducted using the Student's T-test. Linear regression and Pearson correlation analysis were performed in the TMAs. Survival analysis was performed with the Kaplan-Meier and Log-rank tests. The Cox proportional hazards model was used to determine the independent factors that influenced survival and recurrence based on variables selected from the univariate analysis. P-values less than 0.05were considered statistically significant.
Results
Snail promoted CRC tumorigenesis and invasion by up regulating FOXK1 expression
It was previously revealed that overexpression of Snail up regulated FOXK1 in SW480 CRC cells using gene expression profiling (https://www.ncbi.nlm.nih.gov/ geoprofiles/100447371). Here, we first investigated whether FOXK1 and Snail expression levels were correlated in CRC. To this end, we analyzed the expression of FOXK1 and Snail in eight freshly collected CRC biopsies. Western blot analyses indicated that both FOXK1 and Snail were significantly up regulated in all tumor samples examined, compared with the paired adjacent noncancerous tissues from the same patients (Fig. 1A) . The protein expression of FOXK1 was positively correlated with Snail expression (Fig. 1B) . In addition, Spearman correlation analysis showed a positive correlation between FOXK1 and Snail expression (Fig. 1C) . Moreover, the downregulation of Snail decreased FOXK1 expression in three colon cancer cell lines (Fig. 1D) . Next, we analyzed FOXK1 and Snail expression patterns using TMAs. We found that positive FOXK1 and Snail signals were strongly expressed in only the carcinoma cells of CRC samples as shown in Fig. 1E . In contrast, adjacent normal Protein-protein interaction analysis using the STRING database showed that there was no interaction between the two proteins (https://string-db.org/).To determine whether Snail could bind to the FOXK1 promoter, we scanned the promoter region (<600 bp) of human FOXK1 for the E-box consensus sequence and found two potential binding sites: -476 to -482 (E-box 1, Snail1) and -576 to -582 (E-box 1, Snail2) from the transcription initiation site (Fig. 1F) .We cloned the promoter regions E-box 1 (FOXK1p1) and E-box 2 (FOXK1p2) of human FOXK1 upstream of a luciferase gene in a reporter plasmid. Transient transfections were performed to investigate whether the FOXK1 promoter was activated by Snail overexpression. Dual-luciferase assays showed that FOXK1p1 activity in Snail cells increased 11-fold compared with empty vectortransfected cells, whereas the magnification exhibited a slight decrease with FOXK1p2 transfection (Fig. 1G) . To verify the functional relationship between E-box binding site 1 and FOXK1 promoter activity, a mutation was introduced into FOXK1p1 (FOXK1p1-mut1) by site-directed mutagenesis that eliminated its transcriptional activity (Fig. 1H) .To confirm that Snail could physically bind to the FOXK1 promoter in vivo, we performed chromatin immunoprecipitation (ChIP) assays in CRC cell lines expressing endogenous Snail. The FOXK1 promoter region containing site 1 (E-box 1) exhibited significant enrichment after immunoprecipitation with an anti-Snail antibody (Fig. 1I ).These studies suggested that Snail promoted CRC tumorigenesis and invasion by transactivating FOXK1 expression. 
Snail-FOXK1 axis promotes EMT-mediated CRC cells invasion and metastasis
To investigate whether Snail regulates FOXK1 in CRC, we downregulated FOXK1 in Snailoverexpressing SW480 cells using siRNA, and confirmed FOXK1 knockdown by western blot analysis ( Fig. 2A) . Then we examined the morphologic features of these cells. Pooled stable vector transfectants displayed a round or flat morphology with short cytoplasmic processes. However, Snail transfectants exhibited a spindle-like, fibroblastic morphology, which is one of the main EMT characteristics. Conversely, FOXK1 knockdown in Snail-overexpressing cells led to EMT reversion (Fig. 2B) .Some reports have shown actin cytoskeleton regulation of the EMT in metastatic cancer cells [12, 26] . Thus, we stained F-actin with phalloidin, followed by immunofluorescence analysis, which showed that Snail-overexpressing cells had an elongated cellular morphology and the presence of F-actin fibers compared with vector cells, a hallmark of the mesenchymal phenotype. Conversely, Snail-overexpressing cells with FOXK1 knockdown exhibited a cobblestone morphology and small F-actin fibers, indicative of a reverse in the EMT process (Fig. 2C) .Moreover, expression of a typical EMT epithelial marker, E-cadherin, was unregulated after FOXK1 knockdown in Snail-overexpressing cells. In contrast, the mesenchymal markers MMP-2, MMP-9, and vimentin were downregulated (Fig. 2D ). In addition, knockdown of FOXK1 in Snail-overexpressing cells led to a decrease in the migratory potential of Snail-overexpressing cells in vitro, as determined by the wound healing assay (Fig. 2E) . Similarly, FOXK1 downregulation in Snail-overexpressing cells decreased the invasion potential of Snail-overexpressing cells (Fig. 2F) . To validate our findings in vivo, we evaluated Snail and FOXK1 expression in serial sections of lymph node metastatic cancer tissues from two patients and found that Snail and FOXK1 were expressed at high and intermediate levels, respectively (Fig. 2G) . Taken together, these data suggest that the Snail-FOXK1 axis promotes EMT-mediated CRC cell invasion and metastasis.
Dysregulation of the Snail-FOXK1 axis is associated with poor prognosis and aggressive progression of CRC
To explore the clinical relevance of FOXK1 and Snail expression, we analyzed their clinicopathological features in CRC. In tumor samples obtained from 100 patients, FOXK1 and Snail expression was significantly correlated with tumor differentiation, lymph node metastasis, and serosal invasion; however, the expression levels were not correlated with age, gender, American Joint Committee on Cancer stage, location, or tumor size. Next, we investigated the correlation between FOXK1 and Snail expression in 100 pairs of adjacent normal colon mucosal tissues and cancer tissues. Semi-quantitative scoring showed that both proteins were expressed at higher levels in cancer tissues than in adjacent normal colorectal mucosa tissues (Fig. 3A) . After calculating the regression coefficient between the expression scores of FOXK1 and Snail, we observed a significant correlation between FOXK1 and Snail (R = 0.6064) in primary CRC (Fig. 3B) .To analyze the correlation between Snail or FOXK1 expression and the prognosis of CRC patients, Kaplan-Meier survival curves were generated. A high positive expression of each protein was correlated with poor outcome (Fig. 3C (a) and (b) ).Double-positive cases that expressed both proteins showed the worst prognosis (Fig. 3C (c) ). Representative IHC images for the tissues are shown in Fig. 3D . To examine the role of the Snail-FOXK1axis in the progression of CRC, we injected enhanced green fluorescent protein (EGFP)-N1, EGFP-Snail, and EGFP-Snail-FOXK1 shRNA-transfected cells expressing green fluorescent protein into nude mice to examine the liver metastasis (Fig. 3E) . At 42 days after injection, mice injected with Snail-overexpressing SW480 cells but not vector-expressing SW480 cells had large metastatic nodules in their livers, whereas mice with FOXK1 knockdown Snail-overexpressing cells had small liver nodules compared with those in the scr shRNA-transfected Snail-overexpressing cells (Fig. 3F) . The presence of liver metastases from CRC was confirmed by histological analysis (Fig. 3G) . As further confirmation that the Snail-FOXK1axis correlates with the EMT, FOXK1 expression was repressed in Snail-overexpressing cells in orthotopic xenograft tumors. Snail overexpression resulted in significant downregulation of E-cadherin in an IHC assay (Fig. 3H) , whereas loss of FOXK1 in Snail-overexpressed cells caused an increase in E-cadherin expression, as Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry determined by qPCR (Fig. 3I) . Taken together, these results indicate that the Snail-FOXK1 axis plays an important role in the EMT and metastasis in CRC.
Cyr61 is a direct target for transcriptional activation by FOXK1
To examine the role of FOXK1 as a transcription factor and to explore its target genes, we performed a TMA using SW480 CRC cells transfected with FOXK1-targeting siRNA or control siRNA. A total of 491 genes were upregulated, and 398 were downregulated. Cyr61 was the most significantly downregulated gene. Because Cyr61 is a key regulator of migration/invasion and the EMT in CRC cells [27, 28] , we focused on Cyr61 as a target of FOXK1. To confirm the TMA data, Cyr61 downregulation by FOXK1siRNA was examined by western blot analysis in SW480 cells. Transfection of FOXK1 siRNA downregulated Cyr61 protein expression (Fig. 4A) . In addition, downregulation of Cyr61 by transfection of FOXK1siRNA in other cell lines (LoVo and SW1116) yielded similar results (Fig. 4A) . Then, we investigated whether Cyr61 was directly regulated by FOXK1. Yang et al [29] . showed that FOXK recognizes the DNA sequence motif, WRTAAAAYA, and regulates the p21, c-Myc, and cyclin-dependent protein kinase 2 genes. We evaluated Cyr61 in the proximal promoter (< 600 bp) regions of FOXK1 and identified one potential FOXK1-binding site at -25 to -31 (Fig. 4B) . The luciferase reporter assay showed that FOXK1 transactivated Cyr61 promoter (Cyr61p) activity. Moreover, site-directed mutagenesis showed that FOXK1-binding sites were critical for FOXK1-induced Cyr61 transactivation (Fig. 4C) . A ChIP assay confirmed the direct binding of FOXK1 to the Cyr61p promoter in CRC cells (Fig. 4D) . These studies suggest that FOXK1 binds to the Cyr61 promoter and upregulates Cyr61 transcriptional activity. Then, we used western blotting to examine FOXK1 and Cyr61 expression in eight pairs of human CRC tissues and matched non-cancerous colon mucosa. As shown in Fig. 
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry 4E, FOXK1 and Cyr61 were significantly upregulated in the eight tumor samples examined compared with the paired adjacent noncancerous tissues from the same patients. The protein expression of FOXK1 was positively correlated with Cyr61 protein expression (Fig.  4F) . In addition, a positive correlation between FOXK1 and Cyr61 expression was found using spearman rank correlation analysis (Fig. 4G) . Next, we investigated the correlation between Cyr61 and FOXK1 expression using TMAs of adjacent normal colon mucosal tissues and cancer tissues. Both proteins were highly expressed in the cancer tissues, but they were either not expressed or were expressed at low levels in normal tissues (Fig. 4H) . These data indicate that FOXK1 transactivates Cyr61 expression and both proteins are associated with tumorigenesis and metastatic potential of CRC.
FOXK1 is critical for Cyr61-mediated EMT phenotypes and metastatic potential in vitro
To investigate whether FOXK1 regulates Cyr61 in CRC, we used siRNA to downregulate Cyr61 expression in FOXK1-overexpressing cells, which was confirmed by western blotting (Fig. 5A) . Then, we examined the morphologic features of the transfected cells. FOXK1 transfectants exhibited long or dendritic-like cytoplasmic processes that were visible by a phase-contrast microscope. Cyr61 knockdown in FOXK1-overexpressing CRC cells exhibited a cobblestone morphology, indicative of reverse EMT (Fig. 5B) . Then, we stained F-actin using phalloidin. Compared with the vector-expressing cells, FOXK1-overexpressing cells showed 
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Cellular Physiology and Biochemistry F-actin staining throughout the cytoplasm and protrusion of the leading edge (Fig. 5C) . Conversely, Cyr61 knockdown in FOXK1-overexpressing cells led to weak and aggregated F-actin filaments that were involved in cancer cell invasion and metastasis. SiRNA-mediated repression of Cyr61 was performed in FOXK1 cells and resulted in decreased vimentin expression as well as decreased expression of mesenchymal markers (vimentin, MMP2, and MMP9) and increased expression of the epithelial marker (E-cadherin) compared with control (FOXK1) cells (Fig. 5D) . Next, we performed the wound healing assay. Knockdown of Cyr61 in FOXK1-overexpressing cells led to the decreased migratory and invasion potential of FOXK1-overexpressing cells in vitro (Fig. 5E,) .In addition, we evaluated FOXK1 and Cyr61expression in regional lymph node metastases in CRC tissue and found a positive correlation between FOXK1 and Cyr61expression using IHC (Fig. 5G) .Taken together, these data suggest that the co-expression of FOXK1 and Cyr61 regulate cell migration, invasion, and the EMT in CRC cells.
Co-expression of FOXK1 and Cyr61 predicts poor prognosis and promotes invasion/ metastasis of CRC cells
To detect the clinical relevance of FOXK1 and Cyr61 expression, we analyzed their clinicopathological features using TMAs in 100 CRC patients. Similar to FOXK1 and Snail expression patterns, FOXK1 and Cyr61 expression was significantly correlated with tumor differentiation, lymph node metastasis, and serosal invasion. Co-expression of FOXK1 and Cyr61 was associated with CRC progression. To validate our findings in vivo, we investigated FOXK1 and Cyr61 expression in 100 pairs of adjacent normal colon mucosal tissues and cancer tissues. Semi-quantitative scoring of FOXK1 and Cyr61 proteins showed that the 
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Cellular Physiology and Biochemistry expression of both proteins in cancerous tissues was significantly higher than that of adjacent normal colon tissues ( Fig. 6B , P < 0.001), and Spearman's correlation analysis showed a positive correlation between FOXK1 and Cyr61 expression (correlation coefficient r = 0.6748, P<0.001, Fig. 6B ).Then, we analyzed the correlation between FOXK1 and Cry61 expression and the prognosis of CRC patients. Kaplan-Meier analysis showed that the high positive expression of each protein was correlated with a poor outcome ( Fig. 6C (a) and (b)).Double-positive cases that expressed both proteins had the worst prognosis ( Fig.  6C (c) ). Patients with positive co-expression of FOXK1 and Cry61 had poorer prognosis. Representative IHC images for tissues are shown in Fig. 6D .To investigate whether FOXK1 is critical for Cyr61-mediated EMT regulation invivo, shRNA-mediated repression of Cyr61 was performed in FOXK1-overexpressing SW480 cells after orthotopic implantation assays (Fig.  6E) . Metastatic nodules in their livers of the FOXK1-overexpressing group were significantly increased compared with those of the vector group (P< 0.001 vs. vector), whereas liver metastatic nodules after Cyr61 knockdown were greatly decreased compared with those in the FOXK1-overexpressing group (Fig. 6E) . The presence of CRC metastasis in the liver was confirmed by histological analysis (Fig. 6F) . Moreover, FOXK1 overexpression resulted in significant loss of the epithelial marker E-cadherin, whereas Cyr61 downregulation in FOXK1-overexpressing cells increased E-cadherin expression, as determined by IHC and qRT-PCR ( Fig. 6G & H) . Thus, FOXK1 appears to play a critical role in inducing the EMT via Cyr61expression.
Discussion
The EMT is a key process that drives cancer metastasis, and downregulation of E-cadherin is a major hallmark of this process [6, 12, 27] . The EMT also relies on genomewide transcriptional reprogramming and global chromatin modification [30] . In this study, we found that the FOXK1 promoter activated Snail and FOXK1 directly transactivated Cyr61 gene expression, thereby contributing to the EMT, and the invasion and migration of CRC In addition, patients with high expression of FOXK1 and Snail or Cyr61 had poorer prognosis than those with low expression. These findings suggest that the Snail-FOXK1-Cyr61 axis pathway plays a pivotal role in the EMT and metastasis in CRC. FOXK1 is a proto-oncoprotein that is overexpressed in various cancer types [31] [32] [33] . Ectopic expression of FOXK1 markedly enhances cell proliferation, migration, and invasion in gastrointestinal cancer cells [15, 26] . We recently demonstrated that FOXK1 induces EMT progression and predicts poor prognosis in human gastric cancer [15, 34] . The Snail super family of zinc-finger transcription factors is involved in processes that cause pronounced cell movements, both during embryonic development and in the acquisition of invasive and migratory properties during tumor progression [16] [17] [18] . Snail and Slug [35] , Twist1 [6] , ZEB1 [3] , and ZEB2 [9] transcription factors act as molecular triggers of the EMT in human cancers. However, the molecular mechanisms underlying the correlation between FOXK1 and Snail in cancer progression remain unclear. A recent study implicated Snail in E-cadherin repression via its ability to bind to elements in the E-cadherin promoter [36] . Here, we analyzed the FOXK1 promoter sequence and found two potential transcription factor Snail-binding sites. Luciferase reporter assays, site-directed mutagenesis, and ChIP assays showed that the overexpression of FOXK1 induced by Snail was dependent on Snailbinding sites within the FOXK1 promoter. Thus, Snail upregulated FOXK1 expression and transactivated its promoter activity. Furthermore, Snail expression was positively correlated with FOXK1 expression. These studies suggest that Snail-induced FOXK1 overexpression plays an important role ininducing the EMT and the aggressiveness of CRC.
Cyr61 is a multifunctional protein involved in human CRC development and progression [23] . Overexpression of Cyr61 may induce the EMT, thereby leading to cancer cell invasion, metastasis, and poor prognosis [24, 27] . The Cyr61 promoter contains several definitive DNA regulatory elements such as the p53-binding domain, SMAD binding element, and HMGA1 and YY1 elements [37] . A recent report showed that the Cyr61 promoter contains a potential Sox4 binding site (-168 bp to-162 bp) and transactivates Cyr61 expression [38] . Microarray analysis showed FOXK1 was involved with Cyr61 in CRC cells. Then, we showed that the Cyr61 promoter contains a putative FOXK1 binding site and recognizes the DNA sequence motif WRTAAAAYA (600bp) [29] . Indeed, we showed that FOXK1 binds to a segment of the Cyr61 promoter, indicating that it directly transactivates Cyr61 gene expression.
TMA, western blotting, and immunofluorescence demonstrated that the distribution pattern of FOXK1 was highly congruent with that of Snail or Cyr61, and that FOXK1 protein expression was highly correlated with Snail or Cyr61 expression. Moreover, a linear correlation between FOXK1 and Snail or FOXK1 and Cyr61 expression was observed in CRC. It was previously reported that Snail is expressed in CRC and predicts the clinical outcome of CRC patients [39] . Similar to the results obtained in a previous study [40] , we showed that cooperation between FOXK1 and Snail or co-expression of FOXK1 with Cyr61 predicts poor prognosis. Thus, the results of the present study confirm that FOXK1 and/or Snail and/or Cyr61 overexpression may serve as an unfavorable prognostic biomarker for patients with CRC.
Conclusion
We report that the transcription factor Snail transactivates FOXK1 expression by directly binding to its promoter, which contributes to FOXK1 overexpression in human CRC. Moreover, FOXK1 promotes the EMT and tumor invasion and metastasis by transactivating Cyr61 expression in CRC cells. Thus, targeting the FOXK1-Cyr61-Snail axis may provide a potential therapeutic target for the treatment of CRC.
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